Filing Details
- Accession Number:
- 0001641172-25-015756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-20 09:35:32
- Reporting Period:
- 2025-06-18
- Filing Date:
- 2025-06-20
- Accepted Time:
- 2025-06-20 09:35:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1873835 | Immix Biopharma Inc. | IMMX | Pharmaceutical Preparations (2834) | 454869378 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1889334 | M Ilya Rachman | C/O Immix Biopharma, Inc. 11400 West Olympic Blvd., Suite 200 Los Angeles CA 90064 | Ceo And Chairman | Yes | Yes | No | No |
Transaction Summary
| Purchased: | 2,178 shares | Avg. Price: $2.30 | Total Value: $4,998.51 |
| Number of Shares After Transactions: | 1,138,437 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-18 | 2,178 | $2.30 | 1,138,437 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
